M10 peptide attenuates silica-induced pulmonary fibrosis by inhibiting Smad2 phosphorylation.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- M10 peptide attenuates silica-induced pulmonary fibrosis by inhibiting Smad2 phosphorylation.
- Published In:
- Toxicology and applied pharmacology, 376, 46-57 (2019)
- Authors:
- Li, Yan(7), Ji, Xiaoming, Yao, Wenxi, Pan, Honghong, Li, Ping, Liu, Yi, Yuan, Jiali, Xu, Qi, Ni, Chunhui
- Database ID:
- RPEP-04329
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04329APA
Li, Yan; Ji, Xiaoming; Yao, Wenxi; Pan, Honghong; Li, Ping; Liu, Yi; Yuan, Jiali; Xu, Qi; Ni, Chunhui. (2019). M10 peptide attenuates silica-induced pulmonary fibrosis by inhibiting Smad2 phosphorylation.. Toxicology and applied pharmacology, 376, 46-57. https://doi.org/10.1016/j.taap.2019.05.015
MLA
Li, Yan, et al. "M10 peptide attenuates silica-induced pulmonary fibrosis by inhibiting Smad2 phosphorylation.." Toxicology and applied pharmacology, 2019. https://doi.org/10.1016/j.taap.2019.05.015
RethinkPeptides
RethinkPeptides Research Database. "M10 peptide attenuates silica-induced pulmonary fibrosis by ..." RPEP-04329. Retrieved from https://rethinkpeptides.com/research/li-2019-m10-peptide-attenuates-silicainduced
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.